S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
S&P 500   3,145.91 (+0.91%)
DOW   28,015.06 (+1.22%)
QQQ   205.00 (+1.07%)
AAPL   270.71 (+1.93%)
FB   201.05 (+0.85%)
MSFT   151.75 (+1.21%)
GOOGL   1,339.39 (+0.94%)
AMZN   1,751.60 (+0.64%)
CGC   18.65 (+0.27%)
NVDA   212.17 (+1.64%)
MU   47.93 (+2.81%)
BABA   201.89 (+0.95%)
GE   11.10 (+2.87%)
TSLA   335.89 (+1.67%)
T   38.20 (+0.03%)
AMD   39.63 (+0.03%)
ACB   2.43 (-0.41%)
F   9.02 (+1.01%)
PRI   135.68 (+1.03%)
NFLX   307.35 (+1.48%)
BAC   33.67 (+1.75%)
GILD   67.08 (+1.74%)
DIS   147.66 (+0.15%)
Log in

OTCMKTS:LXRP - Lexaria Bioscience Stock Price, Forecast & News

$0.40
-0.01 (-2.44 %)
(As of 12/6/2019 04:00 PM ET)
Today's Range
$0.36
Now: $0.40
$0.43
50-Day Range
$0.41
MA: $0.54
$0.72
52-Week Range
$0.36
Now: $0.40
$1.69
Volume110,579 shs
Average Volume109,835 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
Lexaria Bioscience Corp. engages in the development of strategic partnerships and in the proprietary nutrient infusion technologies for the production of superfoods. It operates through the IP Licensing and Consumer Products segments. The company was founded on December 9, 2004 and is headquartered in Kelowna, Canada.

Industry, Sector and Symbol

Industry Packaged Foods
Sub-IndustryN/A
SectorConsumer Defensive
Current SymbolOTCMKTS:LXRP
CUSIP52886N208
Phone(250) 765-6424

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive LXRP News and Ratings via Email

Sign-up to receive the latest news and ratings for LXRP and its competitors with MarketBeat's FREE daily newsletter.


Lexaria Bioscience (OTCMKTS:LXRP) Frequently Asked Questions

What is Lexaria Bioscience's stock symbol?

Lexaria Bioscience trades on the OTCMKTS under the ticker symbol "LXRP."

Has Lexaria Bioscience been receiving favorable news coverage?

News headlines about LXRP stock have been trending somewhat negative on Friday, according to InfoTrie Sentiment Analysis. InfoTrie rates the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Lexaria Bioscience earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave news coverage about the oil and gas exploration company a news buzz of 0.0 out of 10, meaning that recent news coverage is extremely unlikely to have an impact on the stock's share price in the near future. View News Stories for Lexaria Bioscience.

Who are some of Lexaria Bioscience's key competitors?

What other stocks do shareholders of Lexaria Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Lexaria Bioscience investors own include Canopy Growth (CGC), Cronos Group (CRON), OrganiGram (OGI), Aurora Cannabis (ACBFF), CV Sciences (CVSI), GW Pharmaceuticals PLC- (GWPH), 22nd Century Group (XXII), Aphria (APHQF), Auxly Cannabis Group (CBWTF) and Emerald Health Therapeutics (EMHTF).

Who are Lexaria Bioscience's key executives?

Lexaria Bioscience's management team includes the folowing people:
  • Christopher A. Bunka, Chairman & Chief Executive Officer
  • John Martin Docherty, President & Director
  • Allan Spissinger, Chief Financial Officer, Secretary & Treasurer
  • Alex Blanchard, Manager-Investor Relations & Communications
  • Ed Ergenzinger, Chief Legal Officer & Senior VP-Innovation

How do I buy shares of Lexaria Bioscience?

Shares of LXRP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Lexaria Bioscience's stock price today?

One share of LXRP stock can currently be purchased for approximately $0.40.

What is Lexaria Bioscience's official website?

The official website for Lexaria Bioscience is http://www.lexariaenergy.com/.

How can I contact Lexaria Bioscience?

Lexaria Bioscience's mailing address is 156 Valleyview Rd, KELOWNA, BC V1X 3M4, Canada. The oil and gas exploration company can be reached via phone at (250) 765-6424.


MarketBeat Community Rating for Lexaria Bioscience (OTCMKTS LXRP)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  54 (Vote Outperform)
Underperform Votes:  64 (Vote Underperform)
Total Votes:  118
MarketBeat's community ratings are surveys of what our community members think about Lexaria Bioscience and other stocks. Vote "Outperform" if you believe LXRP will outperform the S&P 500 over the long term. Vote "Underperform" if you believe LXRP will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/6/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel